Chen Jun

Chen Jun, MD, chief physician, master’s supervisor, currently serves as deputy director of the Pathology Department of Nanjing Drum Tower Hospital, deputy director (in charge) of the hospital’s biobank, and director of the Nanjing Clinical Biobank Quality Control Center. He is good at combining clinical, imaging, genetic testing, etc. to complete difficult pathological diagnosis of hepatobiliary and pancreatic tumors, liver diseases, bone and soft tissue tumors, head and neck tumors, etc. As one of the authors, he participated in the writing of “Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 Edition)”, “CSCO Guidelines for the Diagnosis and Treatment of Biliary Malignant Tumors (2020-2024)”, and “Standardized Pathological Diagnosis Guidelines for Primary Liver Cancer (2015 Edition)”. He is currently a member of the Liver Tumor Special Committee of the China Branch of the International Hepatobiliary and Pancreatic Association, a member of the Biliary Tumor Special Committee of the Chinese Anti-Cancer Association, a member of the Biliary Tumor Committee and Liver Cancer Committee of CSCO, a member of the Pathology Committee of the Chinese Association of Research Hospitals, a standing member of the Pathology Branch of the Jiangsu Provincial Medical Association and leader of the Gastroenterology Group, a standing member of the Tumor Pathology Branch of the Jiangsu Anti-Cancer Association, a standing committee member of the Pancreatic Disease Branch of the Jiangsu Medical Doctors Association, and a member of the Liver Disease Branch of the Jiangsu Medical Association. He has won the “Six Peak Talents of Jiangsu Province”, “Nanjing Young Health Talents”, the second prize of Jiangsu Province Medical Science and Technology Award, the second prize of Jiangsu Province Medical New Technology Introduction Award, etc. He presided over major projects for the development of medical science and technology in Nanjing and other topics. In the past five years, he published 18 papers as the first author or corresponding author, 15 of which were included in SCI.

Translated from the original Chinese source.